Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 111

Sort by

Sort Order Select

Journal Articles

JAK/Rock Inhibitor Rovadicitinib for Glucocorticoid-Refractory or -Dependent Chronic Graft-Versus-Host Disease：Updated Results of Multicenter, Phase 1b/2a Trial

Blood (2024) 144 (Supplement 1): 97.

https://doi.org/10.1182/blood-2024-204703

Published: 2024

Journal Articles

Immunopeptidome Divergence between Mismatched HLA Haplotypes and Survival after Haploidentical HCT: A Retrospective Study from the CIBMTR

Pietro Crivello, Meilun He, Tao Wang, Shahinaz M. Gadalla, Esteban Arrieta-Bolanos, Steven GE Marsh, Stephanie Lee, Yung-Tsi Bolon, Katharina Fleischhauer

Blood (2024) 144 (Supplement 1): 692.

https://doi.org/10.1182/blood-2024-200386

Published: 2024

Journal Articles

Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas

Blood (2024) 143 (13): 1231–1241.

https://doi.org/10.1182/blood.2023022204

Published: 2024

Includes: Supplemental data

Journal Articles

Prediction of Graft-Versus-Host Disease (GVHD) in Recipients of Hematopoietic Cell Transplant(alloHCT) from a Single Mismatched Unrelated Donor Using a Highly Multiplexed Proteomics Assay: MHC-Pepseq

Karamjeet S. Sandhu, John Altin, Tao Wang, Jakob Devos, Medhat Askar, Zachariah DeFilipp, Ketevan Gendzekhadze, Carrie L. Kitko, Stephanie J. Lee, Margaret L. MacMillan, Stephen R. Spellman, Ryotaro Nakamura

Blood (2023) 142 (Supplement 1): 4930.

https://doi.org/10.1182/blood-2023-186724

Published: 2023

Journal Articles

HLA-DRB1 Hed Is Associated with Improved Survival and Decreased Relapse in Patients with Hematologic Malignancies Following Allogeneic Hematopoietic Stem Cell Transplant

Christine Camacho-Bydume, Tao Wang, Diego Chowell, Chirag Krishna, Brian C. Shaffer, Steven Marsh, Sophie Paczesny, Shahinaz M. Gadalla, Meilun He, Yung-Tsi Bolon, Stephen R. Spellman, Stephanie J. Lee, Katharine C. Hsu

Blood (2023) 142 (Supplement 1): 2232.

https://doi.org/10.1182/blood-2023-179543

Published: 2023

Journal Articles

JAK2 V617F Mutation and Associated Chromosomal Alterations Involving JAK2 in Pre-HCT Blood Samples and Transplant Outcomes in Myelofibrosis Subtypes

Maryam Rafati, Derek W Brown, Weiyin Zhou, Kristine Jones, Wen Luo, Andrew St. Martin, Youjin Wang, Stephen R. Spellman, Tao Wang, H. Joachim Deeg, Vikas Gupta, Stephanie J. Lee, Stephen J. Chanock, Mitchell Machiela, Wael Saber, Shahinaz M. Gadalla

Blood (2022) 140 (Supplement 1): 906–908.

https://doi.org/10.1182/blood-2022-163734

Published: 2022

Journal Articles

Does Race/Ethnicity Impact Umbilical Cord Blood Transplant Outcomes in a Contemporary Era?

Karen K. Ballen, Tao Wang, Naya He, Shahrukh Hashmi, Leslie E. Lehmann, William A. Wood, Jr., Hemalatha G. Rangarajan, Wael Saber

Blood (2022) 140 (Supplement 1): 685–686.

https://doi.org/10.1182/blood-2022-159152

Published: 2022

Journal Articles

Development of a Validated Clinical Risk Score to Predict the Incidence of Acute Graft Versus Host Disease after Allogeneic Hematopoietic Cell Transplantation: A CIBMTR Analysis

Caden Ulschmid, Xiao Li, Tao Wang, Brent Logan, Joseph Pidala, Margaret L. MacMillan, Carrie Lynn Kitko, Stephanie J. Lee, Stephen R. Spellman, Wael Saber

Blood (2022) 140 (Supplement 1): 279–281.

https://doi.org/10.1182/blood-2022-163263

Published: 2022

Journal Articles

Racial, Ethnic and Socioeconomic Disparity in Outcomes of Patients with Chronic Graft-Versus-Host Disease: A CIBMTR Analysis

Nosha Farhadfar, Zeina Al-Mansour, Tao Wang, Karen Chen, Joseph Pidala, Margaret L. MacMillan, Carrie Lynn Kitko, Stephen R. Spellman, John R. Wingard, Stephanie J. Lee

Blood (2022) 140 (Supplement 1): 5108–5109.

https://doi.org/10.1182/blood-2022-163537

Published: 2022

Journal Articles

JAK/Rock Inhibitor TQ05105 for Glucocorticoid-Refractory or -Dependent Chronic Graft-Versus-Host Disease：Preliminary Analysis Results of a Phase 1b/2 Study

Yanmin Zhao, Lifan Tu, Yishan Ye, Yi Luo, Jimin Shi, Jian Yu, Yi Yu, Fankai Meng, Tao Wang, He Huang

Blood (2022) 140 (Supplement 1): 10505–10506.

https://doi.org/10.1182/blood-2022-164659

Published: 2022

Journal Articles

Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes

Blood (2022) 140 (8): 909–921.

https://doi.org/10.1182/blood.2022016508

Published: 2022

Includes: Supplemental data

Journal Articles

A core group of structurally similar HLA-DPB1 alleles drives permissiveness after hematopoietic cell transplantation

Esteban Arrieta-Bolaños, Pietro Crivello, Meilun He, Tao Wang, Shahinaz M. Gadalla, Sophie Paczesny, Steven G. E. Marsh, Stephanie J. Lee, Stephen R. Spellman, Yung-Tsi Bolon, Katharina Fleischhauer

Blood (2022) 140 (6): 659–663.

https://doi.org/10.1182/blood.2022015708

Published: 2022

Includes: Supplemental data

Journal Articles

Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs

Blood (2022) 140 (1): 16–24.

https://doi.org/10.1182/blood.2022015728

Published: 2022

Journal Articles

HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide

Blood (2022) 139 (10): 1452–1468.

https://doi.org/10.1182/blood.2021013443

Published: 2022

Includes: Supplemental data

Journal Articles

KIR-HLA Interactions Lack Clinical Utility in Matched Unrelated Donor Transplantation for AML: An Analysis of the CIBMTR and DRST Registries

Joshua A Fein, Roni Shouval, Elizabeth Krieger, Henning Baldauf, Katharina Fleischhauer, Nicolaus Kroeger, Mary M. Horowitz, Martin Maiers, Karl-Johan Malmberg, Jeffrey S. Miller, Mohamad Mohty, Arnon Nagler, Rizwan Romee, Johannes Schetelig, Stephen R. Spellman, Amir Ahmed Toor, Tao Wang, Daniel J. Weisdorf, John Koreth

Blood (2021) 138 (Supplement 1): 419.

https://doi.org/10.1182/blood-2021-149935

Published: 2021

Journal Articles

Germline-Somatic Interactions in Myelofibrosis Susceptibility

Blood (2021) 138 (Supplement 1): 313.

https://doi.org/10.1182/blood-2021-150634

Published: 2021

Journal Articles

Haploidentical Vs. Matched Unrelated Donor Transplants Using Post-Transplant Cyclophosphamide for Lymphoma: A Joint CIBMTR/EBMT Study

Alberto Mussetti, Abraham S. Kanate, Tao Wang, Meilun He, Mehdi Hamadani, Hervé Finel, Sr., Ariane Boumendil, Sr., Bertram Glass, Luca Castagna, Didier Blaise, Steven G.E. Marsh, Sophie Paczesny, Shahinaz M. Gadalla, Peter Dreger, Stephen R. Spellman, Stephanie J. Lee, Yung-Tsi Bolon, Anna Sureda

Blood (2021) 138 (Supplement 1): 174.

https://doi.org/10.1182/blood-2021-151197

Published: 2021

Journal Articles

Allogeneic NKT Cells Expressing a CD19-Specific CAR in Patients with Relapsed or Refractory B-Cell Malignancies: An Interim Analysis

Carlos A. Ramos, Amy N. Courtney, Simon N. Robinson, Olga Dakhova, Premal D. Lulla, Rammurti Kamble, George Carrum, Tao Wang, Chunchao Zhang, Erica Di Pierro, Leonid S. Metelitsa

Blood (2021) 138 (Supplement 1): 2819.

https://doi.org/10.1182/blood-2021-149712

Published: 2021

Journal Articles

A Refined Model of HLA-DP Permissiveness Improves Stratification of Acute Graft-Versus-Host Disease Risks after Unrelated Hematopoietic Cell Transplantation: A Retrospective Study from the CIBMTR

Esteban Arrieta-Bolanos, Pietro Crivello, Meilun He, Tao Wang, Shahinaz M. Gadalla, Sophie Paczesny, Steven G.E. Marsh, Stephanie J. Lee, Stephen R. Spellman, Yung-Tsi Bolon, Katharina Fleischhauer

Blood (2021) 138 (Supplement 1): 2890.

https://doi.org/10.1182/blood-2021-146957

Published: 2021

Journal Articles

Bacterial Prophylaxis in Patients with Acute Gvhd; Who Is at Risk for Bloodstream Infections?

Whitney Wallis, Alison Gulbis, Tao Wang, Karen Chen, Carrie Lynn Kitko, Margaret L. MacMillan, Joseph Pidala, Marcie L. Riches, Stephen R. Spellman, Mukta Arora, Amin M. Alousi

Blood (2021) 138 (Supplement 1): 2870.

https://doi.org/10.1182/blood-2021-148890

Published: 2021

NARROW

JAK/Rock Inhibitor Rovadicitinib for Glucocorticoid-Refractory or -Dependent Chronic Graft-Versus-Host Disease：Updated Results of Multicenter, Phase 1b/2a Trial

Immunopeptidome Divergence between Mismatched HLA Haplotypes and Survival after Haploidentical HCT: A Retrospective Study from the CIBMTR

Antitumor efficacy and safety of unedited autologous CD5.CAR T cells in relapsed/refractory mature T-cell lymphomas

Prediction of Graft-Versus-Host Disease (GVHD) in Recipients of Hematopoietic Cell Transplant(alloHCT) from a Single Mismatched Unrelated Donor Using a Highly Multiplexed Proteomics Assay: MHC-Pepseq

HLA-DRB1 Hed Is Associated with Improved Survival and Decreased Relapse in Patients with Hematologic Malignancies Following Allogeneic Hematopoietic Stem Cell Transplant

JAK2 V617F Mutation and Associated Chromosomal Alterations Involving JAK2 in Pre-HCT Blood Samples and Transplant Outcomes in Myelofibrosis Subtypes

Does Race/Ethnicity Impact Umbilical Cord Blood Transplant Outcomes in a Contemporary Era?

Development of a Validated Clinical Risk Score to Predict the Incidence of Acute Graft Versus Host Disease after Allogeneic Hematopoietic Cell Transplantation: A CIBMTR Analysis

Racial, Ethnic and Socioeconomic Disparity in Outcomes of Patients with Chronic Graft-Versus-Host Disease: A CIBMTR Analysis

JAK/Rock Inhibitor TQ05105 for Glucocorticoid-Refractory or -Dependent Chronic Graft-Versus-Host Disease：Preliminary Analysis Results of a Phase 1b/2 Study

Genetic testing in severe aplastic anemia is required for optimal hematopoietic cell transplant outcomes

A core group of structurally similar HLA-DPB1 alleles drives permissiveness after hematopoietic cell transplantation

Long-term follow-up for the development of subsequent malignancies in patients treated with genetically modified IECs

HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide

KIR-HLA Interactions Lack Clinical Utility in Matched Unrelated Donor Transplantation for AML: An Analysis of the CIBMTR and DRST Registries

Germline-Somatic Interactions in Myelofibrosis Susceptibility

Haploidentical Vs. Matched Unrelated Donor Transplants Using Post-Transplant Cyclophosphamide for Lymphoma: A Joint CIBMTR/EBMT Study

Allogeneic NKT Cells Expressing a CD19-Specific CAR in Patients with Relapsed or Refractory B-Cell Malignancies: An Interim Analysis

A Refined Model of HLA-DP Permissiveness Improves Stratification of Acute Graft-Versus-Host Disease Risks after Unrelated Hematopoietic Cell Transplantation: A Retrospective Study from the CIBMTR

Bacterial Prophylaxis in Patients with Acute Gvhd; Who Is at Risk for Bloodstream Infections?

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only